2008
DOI: 10.1016/j.steroids.2007.12.029
|View full text |Cite
|
Sign up to set email alerts
|

Aldosterone: From biosynthesis to non-genomic action onto the proteome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…These effects are not mediated by gene expression but appear to involve activation of different signaling pathways including PKC, phosphoinositide 3-kinase, and c-Src and of transporters including the Na ϩ /H ϩ exchanger, the Na-K-2Cl cotransporter, and a Mg 2ϩ transporter transient receptor potential melastatin 7 cation channel (TRPM7) (216,582,595). The nongenomic effects are thought to be mediated by interaction with MR or other receptors (including G protein-coupled estrogen receptor 1, GPER1) which are located in the cell membrane (unlike the classical cytosolic/nuclear receptors) (101).…”
Section: B Nonepithelial and Nongenomic Actionsmentioning
confidence: 99%
“…These effects are not mediated by gene expression but appear to involve activation of different signaling pathways including PKC, phosphoinositide 3-kinase, and c-Src and of transporters including the Na ϩ /H ϩ exchanger, the Na-K-2Cl cotransporter, and a Mg 2ϩ transporter transient receptor potential melastatin 7 cation channel (TRPM7) (216,582,595). The nongenomic effects are thought to be mediated by interaction with MR or other receptors (including G protein-coupled estrogen receptor 1, GPER1) which are located in the cell membrane (unlike the classical cytosolic/nuclear receptors) (101).…”
Section: B Nonepithelial and Nongenomic Actionsmentioning
confidence: 99%
“…Linking CTS with aldosterone action, it has also been shown that both share common intracellular signaling pathways [20,21]. …”
Section: Introductionmentioning
confidence: 99%
“…The applicability of the protocol for eukaryotic proteomes was proven using a simple eukaryotic organism, the fission yeast S. pombe. This selection furthermore allowed us to complement the proteomic studies on this model organism, previously reported by us [1,18,19]. After proving the general applicability to eukaryotic proteomes, we set the focus of the study onto human hepatocytes.…”
Section: Introductionmentioning
confidence: 99%